- General Drug Summary
- Drug Name
- Argininosuccinate
- Structure
- Summary In Neonatal Jaundice
-
1 record(s) for Argininosuccinate Adverse Event in Neonatal Jaundice.
- PMID
- Drug Name
- Efficacy
- Evidence
- 11343052
- Argininosuccinate
- Adverse Event
- Clinical Trial
- Summary
- Adult-onset type II citrullinemia, characterized by a liver-specific argininosuccinate synthetase deficiency,may be associated with infantile cholestatic disease.
- Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. The Journal of pediatrics, 2001 May [Go to PubMed]
- Adult-onset type II citrullinemia, characterized by a liver-specific argininosuccinate synthetase deficiency, is caused by a deficiency of citrin that is encoded by the SLC25A13 gene. Three patients with infantile cholestatic jaundice were found to have mutations of the SLC25A13 gene. Adult-onset type II citrullinemia may be associated with infantile cholestatic disease.
